Skip to content
PeptideAgent

Compounding pharmacies in Alabama

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The Alabama State Board of Pharmacy regulates compounding pharmacies in Alabama. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Alabama at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Alabama

No verified compounding pharmacies serving Alabama are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Alabama

The Alabama State Board of Pharmacy regulates pharmacies under the Alabama Pharmacy Practice Act (Code of Alabama Title 34, Chapter 23) and Administrative Code chapter 680-X-2. Alabama has no state bulks list; a peptide may be compounded only if it is an approved drug component, has a USP or NF monograph, or appears on the FDA 503A bulks list. Any pharmacy located outside Alabama that ships, mails, or delivers prescription drugs to an Alabama patient must hold a nonresident (mail order) permit from the Board under rule 680-X-2-.07 and Code sections 34-23-30 and 34-23-31, and must designate an Alabama agent for service of process. The Board has issued a public statement on compounded semaglutide that rejects the use of semaglutide salt forms (sodium and acetate) because they are not the active ingredient in the approved product. Injectable peptides are sterile parenteral products, which Board rule 680-X-2-.19 (Parenteral Sterile Therapy) governs: a pharmacy compounding parenteral products must be certified by the Board as a parenteral sterile compounding pharmacy. Board rule 680-X-2-.43 (Requirements for Compounding) requires every compounding pharmacy to follow current USP-NF standards. [1] [2] [3] [4] [5] [7] [9]

Compounded GLP-1 access in Alabama

Compounded semaglutide and tirzepatide are limited to the federal exception for documented patient-specific needs since the FDA shortage declarations ended in 2025, and Alabama is one of the states whose Board of Pharmacy publicly warned pharmacies about semaglutide copies and salt forms. The Board of Medical Examiners has also published fraud alerts about counterfeit Ozempic and unlicensed sellers. [3] [7] [8] [12]

Research use only sellers in Alabama

Selling prescription drugs to Alabama consumers requires a Board of Pharmacy permit, and "research use only" peptides sold for human injection are unapproved new drugs under 21 U.S.C. 331 and 355 regardless of labeling. The Alabama Board of Medical Examiners has warned the public about unlicensed sellers of semaglutide and tirzepatide, and these products are not dispensed by a pharmacist and carry no Alabama consumer protections. In 2026 the Board of Medical Examiners issued a notice that no physician may compound, administer, or dispense a non-FDA-approved or research-grade peptide or delegate that to a CRNP, CNM, or PA, and that physicians must buy all prescription products, drugs, and ingredients from entities permitted by the Alabama State Board of Pharmacy. No research-grade peptide is on any approved CRNP, CNM, or PA formulary, and a patient consent form does not remove the provider's liability. [1] [8] [13] [14]

Alabama notes on specific peptides

  • Semaglutide: Available branded from any Alabama pharmacy by prescription, including telehealth prescriptions under sections 34-24-701 through 34-24-707. The Alabama State Board of Pharmacy has stated that compounding with semaglutide sodium or semaglutide acetate is not acceptable, and compounded semaglutide base is limited to the federal patient-specific exception since the 503A grace period ended April 22, 2025. [6] [7] [12]

How to check a compounding pharmacy in Alabama

  1. Search the Alabama State Board of Pharmacy license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Alabama requires before it ships to you. [1] [2] [3] [4] [5] [7] [9]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Alabama. [1] [8] [13] [14]

Common questions in Alabama

Is compounded semaglutide or tirzepatide still available in Alabama?

Only in limited, patient-specific cases. The federal shortage allowances ended in 2025, and the Alabama State Board of Pharmacy has publicly stated that semaglutide sodium and acetate salts are not acceptable starting materials. A pharmacy compounding GLP-1 copies routinely is exposed to both FDA action and Board discipline. [7] [12]

How do I check whether a mail-order pharmacy can ship compounded peptides to Alabama?

Search the Alabama State Board of Pharmacy license verification for the pharmacy. Rule 680-X-2-.07 bars a nonresident pharmacy from shipping prescription drugs to an Alabama patient unless it is registered with the Board, and the pharmacy must also hold a valid permit in its home state. If it is not listed, the shipment is unlawful in Alabama. [1] [3]

Can an Alabama pharmacy compound BPC-157 or other unapproved peptides?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [1] [10] [11]

All peptide legal questions for Alabama

Sources

  1. [1]Alabama State Board of Pharmacy
  2. [2]Alabama State Board of Pharmacy: statutes and rules (Title 34, Chapter 23 and Administrative Code chapter 680-X-2)
  3. [3]Alabama Administrative Code rule 680-X-2-.07, Mail order prescriptions (nonresident pharmacy registration)
  4. [4]Alabama Administrative Code rule 680-X-2-.19, Parenteral Sterile Therapy (last amended May 15, 2025), accessed 2026-09-22
  5. [5]Alabama Administrative Code rule 680-X-2-.43, Requirements for Compounding (USP-NF standards), accessed 2026-09-22
  6. [6]Code of Alabama section 34-24-703, Duties of physicians providing telehealth medical services (Act 2022-302)
  7. [7]Alabama State Board of Pharmacy position on compounded semaglutide (salt forms), hosted by the Board of Medical Examiners
  8. [8]Alabama Board of Medical Examiners: fraudulent activity alert on Ozempic, semaglutide, and tirzepatide
  9. [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  10. [10]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA